Individual differences in the plasma half-lives of lipid soluble drugs in man.
D000328:Adult; D000983:Antipyrine / Q000097:blood*; D005260:Female; D006207:Half-Life; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D010113:Oxyphenbutazone / Q000097:blood*; D010653:Phenylbutazone / Q000097:blood*; D012995:Solubility; D013997:Time Factors
D010653:Phenylbutazone; D010113:Oxyphenbutazone; D000983:Antipyrine